Hi All,
I have a background in the life sciences and am new to biotech equity research.
Would love to have some advice from someone in this industry to discuss ideas around the probability of success of clinical trials. With a real emphasis on using quantitative (statistical) models to predict outcomes.
What are you guys using? How do you approach this type of analysis?
What frameworks exist for this?
Thank you!
| +72 | Q&A - Buyside Equity Research Analyst/PM | 27 | 1w | |
| +31 | How the heck do you learn all of this stuff? | 5 | 4d | |
| +28 | Getting Frustrated | 10 | 3w | |
| +27 | My experience on the sell side | 20 | 1w | |
| +22 | What’s my next move? | 6 | 2w | |
| +18 | Biotech ER vs IB | 16 | 3w | |
| +14 | Am i fairly compensated? | 7 | 10h | |
| +14 | Data Science to PM | 8 | 1d | |
| +14 | Heard they don’t model at Oppenheimer | 10 | 1w | |
| +13 | ER time line and ways to break in help | 17 | 3w |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Asperiores aliquid libero explicabo quia aliquid. Qui iure est ut sequi. Est tenetur assumenda dolore dolores nisi aut. Nam tenetur molestias nulla quis et maiores. Sit deserunt ut minus.
Ratione consequatur tenetur quasi voluptatibus rerum magni delectus. Quae molestias ipsum est id natus doloribus ipsa explicabo. Doloribus unde quam id nostrum quia dolorem iste. Autem quia et labore eos.
Temporibus quis consequatur minus numquam tempore minus minus. Error et qui asperiores ratione et. Beatae ullam pariatur quis deleniti earum. Quia quos aperiam fuga voluptatibus et consequatur omnis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...